VILL: A Potential Drug Target Or Biomarker for Diseases (G50853)

Target Name: VILL

NCBI ID: G50853

VILL

VILL: A Potential Drug Target Or Biomarker for Diseases

VILL (Villin-like) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is characterized by its unique structure, which is similar to that of the villin protein found in the villin gene family. This similarity has led to the belief that VILL may be a drug target or biomarker for various diseases.

The villin gene family is a gene family that is characterized by the presence of a specific intron-protein-intron (IPI) region in the gene. This region is responsible for the production of the villin protein, which is a key regulator of the unfolded protein response (UPR) pathway. The UPR is a critical pathway that helps to maintain the stability and function of proteins, and is involved in a wide range of cellular processes, including stress response, cell division, and inflammation.

VILL is similar to the villin protein in terms of its structure and function. Like the villin protein, VILL is a 21-kDa protein that is expressed in various tissues throughout the body. It is highly conserved, with a calculated molecular weight of 46.1 kDa. VILL is also involved in the UPR pathway, and has been shown to play a role in regulating the expression of various genes in the cell.

One of the key potential benefits of targeting VILL is its potential as a drug target. The UPR is a critical pathway that is involved in many cellular processes, and is Therefore, targeting VILL may be a way to target a wide range of cellular processes. This is because changes in the UPR pathway have been implicated in many diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In addition to its potential as a drug target, VILL may also be a biomarker for certain diseases. The villin gene family has been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Therefore, VILL may be a useful biomarker for these diseases. For example, studies have shown that VILL is often reduced in the brains of individuals with Alzheimer's disease, a neurodegenerative disease. Additionally, VILL has been shown to be involved in the development of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease.

In conclusion, VILL is a protein that is expressed in various tissues throughout the body and is characterized by its similarity to the villin protein found in the villin gene family. This similarity has led to the belief that VILL may be a drug target or biomarker for various diseases. Further research is needed to determine the exact role of VILL in cellular processes and to explore its potential as a drug or biomarker.

Protein Name: Villin Like

Functions: Possible tumor suppressor

The "VILL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VILL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets